BeamishRE. Heart failure: The ironic failure of success (letter). Can J Cardiol1994; 10:603.
2.
The Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med1997; 336:525–33.
3.
CONSENSUS Trial Study Group.Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med1987; 316:1429–35.
4.
PackerM. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol1992; 20:248–54.
5.
WeberKTAndrewsVJanickiJSLikoffMReichekN. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure. Circulation1982; 66:1262–7.
6.
PackerMFrancisGSAbramsJCobbFREichhornEJGilesJD, Oral milrinone increases the risk of sudden death in severe chronic heart failure: The PROMISE trial (abstract). Circulation1991; 84(suppl II):II–310.
7.
ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol1995; 26:1376–98.
8.
MasonDTBraunwaldE. Studies of digitalis: X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and patients with heart failure. J Clin Invest1964; 43:532–43.
9.
van VeldhuisenDJMan in't VeldAJDunselmanPHJMBoomsmaF, Lie KI, for the DIMT Study Group. Double-blind, placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: Results of the Dutch Ibopamine Multicenter Trial (DIMT)J Am Coll Cardiol1993; 22:1564–73.
10.
RibnerHSPlucinskiDAHsiehAMBresnahanDMolteniAAskenaziJ, Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic—hormonal study. Am J Cardiol1985; 56:896–904.
11.
CovitABSchaerGLSealyJELaraghJHCodyRJ. Suppression of the renin—angiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med1983; 75:445–7.
12.
FerrariAGregoriniLFerrariMCPretiLManciaG. Digitalis and baroreceptor reflexes in man. Circulation1981; 63:279–85.
13.
FergusonDWAbboudFMMarkAL. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation1984; 69:451–60.
14.
BrouwerJvan VeldhuisenDJMan in't VeldAJDunselmanPHJMHaaksmaJLieKI. Circadian pattern of heart rate variability in heart failure is progressively disturbed with increasing neurohormonal activation (abstract). J Am Coll Cardiol1994; 23(suppl A):392A.
15.
JaeschkeROxmanADGuyattGH. To what extent do congestive heart failure patients in normal sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. Am J Med1990; 88:279–86.
16.
UretskyBFYoungJBShahidiFEYellenLGHarrisonMC, Jolly MK, on behalf of the PROVED Investigative Group. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure. J Am Coll Cardiol1993; 22:955–62.
17.
PackerMGheorghiadeMYoungJBConstantiniPJAdamsKF, Cody RJ, for the RADIANCE Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med1993; 329:1–7.
18.
de BonoD. Digoxin in eurhythmic heart failure: PROVED or “not proven”?Lancet1994; 343:128–9.
19.
JustHDrexlerHTaylorSHSiegristJSchulgenG, Schumacher M, for the CADS Study Group. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. Herz1993; 18(suppl 1):436–43.
20.
KleberFXThyroff-FriesingerU. Ibopamine versus digoxin in the treatment of mild congestive heart failure. Cardiology1990; 77(suppl 5):75–80.
21.
YusefSGargRSmithRDagenaisGMontagueTArnoldM, Which heart failure patients benefit the most from long term digoxin therapy (abstract)?Circulation1996; 94(suppl I):I–23.
22.
DovalHCNulDRGrancelliHOPerroneSVBortmanGR, Curiel R, for Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet1994; 344:493–8.
23.
SinghSNFletcherRDFisherSGLewisHDDeedwaniaPCMassieBM, and the CHF STAT Investigators. Results of the Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (Veterans Affairs Cooperative Study Program #320) (abstract). Circulation1994; 90:I-546.
24.
PackerMO'ConnerCMGhaliJKPresslerMLCarsonPEBelkinRN, for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med1996; 335:1107–14.
25.
KøberLTorp-PedersenCGadsbøllNHildebrandtPHøilund-CarlsenPF. Is digoxin an independent risk factor for long-term mortality after acute myocardial infarction?Eur Heart J1994; 15:382–8.
26.
LuuMStevensonWGStevensonLWBaronKWaldenJ. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation1989; 80:1675–80.
27.
SOLVD Investigators.Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med1991; 325:293–302.
28.
GradmanADeedwaniaPCodyRMassieBPackerMPittB, for the Captopril—Digoxin Study Group. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol1989; 14:564–70.
29.
PackerM. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation1992; 85(suppl I):I50–6.
30.
PackerMBristowMRCohnJNColucciWSFowlerMBGilbertEM, for the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med1996; 334:1349–55.
31.
StevensonWGWienerIYeatmanLWohlgelertnerDWeissJN. Complicated atherosclerotic lesions: A potential cause of ischemic ventricular arrhythmias in cardiac arrest survivors who do not have inducible ventricular tachycardia. Am Heart J1988; 116:1–6.
32.
ManciniDMBenottiJRElkayamUFrancisGSHessMLMassieBM, and the PROMISE Investigators and Coordinators. Antiarrhythmic drug use and high serum levels of digoxin are independent adverse prognostic factors in patients with chronic heart failure (abstract). Circulation1991; 84(suppl II):II–243.
33.
KrumHBiggerJTGoldsmithRLPackerM. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol1995; 25:289–94.
34.
GheorghiadeMHallVBJacobsonGAlamMRosmanHGoldsteinS. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation1995; 92:1801–7.
35.
FergusenJJ. Meeting highlights of the American College of Cardiology 45th Annual Scientific Sessions, Orlando, FL, March 24–27, 1996. Circulation1996; 94:3.
36.
The Captopril—Digoxin Multicenter Research Group.Comparative effects of therapy with Captopril and digoxin in patients with mild to moderate heart failure. JAMA1988; 259:539–44.
